... Food and Drug Administration (FDA) to treat HS include: Adalimumab (Humira) Bimekizumab-bkzx (Bimzelx) Secukinumab (Cosentyx) Infliximab (Remicade) and ustekinumab (Stelara) are not FDA-approved for HS, but they’re sometimes prescribed off-label to treat cases of HS that haven’t responded to other treatments. ...
Treatments for Hidradenitis Suppurativa
... Food and Drug Administration (FDA) to treat HS include: Adalimumab (Humira) Bimekizumab-bkzx (Bimzelx) Secukinumab (Cosentyx) Infliximab (Remicade) and ustekinumab (Stelara) are not FDA-approved for HS, but they’re sometimes prescribed off-label to treat cases of HS that haven’t responded to other treatments. ...
... However, two other biologics — ustekinumab (Stelara) and infliximab (Remicade) — are sometimes prescribed off-label for HS. This means they’re used for a purpose different from what they were originally approved for.Do You Have To Inject Your Biologic Therapy? ...
Biologic Injections for Hidradenitis Suppurativa: Facing Your Fears
... However, two other biologics — ustekinumab (Stelara) and infliximab (Remicade) — are sometimes prescribed off-label for HS. This means they’re used for a purpose different from what they were originally approved for.Do You Have To Inject Your Biologic Therapy? ...